Skip to main content
Equibles

Steward Partners Investment Advisory, LLC

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 1723397 STAMFORD, CT
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$178,946
+$51,436 QoQ
Shares Held
34,085
-0.6% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#39
of 98 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Steward Partners Investment Advisory, LLC holds $15,321,816 across 33 Drug Manufacturers - Specialty & Generic names. LFCR ranks #9 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 64,872 $4,661,701
2 HROW
Harrow, Inc.
 90,251 $3,832,959
3 LNTH
Lantheus Holdings, Inc.
 18,033 $2,000,581
4 TAK
Takeda Pharmaceutical Co Ltd
 116,008 $1,859,608
5 PCRX
Pacira BioSciences, Inc.
 36,273 $920,246
6 VTRS
Viatris Inc
 29,511 $468,634
7 PBH
Prestige Consumer Healthcare Inc.
 7,030 $332,308
8 HLN
Haleon plc
 27,398 $255,623

All Filings in LFCR

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $178,946 34,085
2026-03-31 $127,510 34,277
2025-12-31 $279,878 34,215
2025-09-30 $249,423 33,889
2025-06-30 $266,019 32,761
2025-03-31 $212,840 30,233
2024-12-31 $201,977 27,184
2024-09-30 $83,139 16,864
2024-06-30 $39,890 7,776
2024-03-31 $22,519 4,241
2023-12-31 $12,776 2,064
2023-09-30 $6,266 830